| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.93B | +73.7% |
| Gross profit | ¥0.11B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.05B | — |
| Gross margin | 11.7% | Net margin 5.0% |
| Revenue Q/Q | +19.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.82B | 88.3% |
| R&D | ¥0.00B | 0.4% |
| SG&A | ¥0.01B | 1.1% |
| Tax & other | ¥0.00B | 0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
酷特智能 ・ 康华生物 ・ 帝科股份 ・ 胜蓝股份 ・ 山水比德 ・ 捷安高科 ・ 首都在线 ・ 中船汉光 ・ 美瑞新材 ・ 锦盛新材 ・ 新强联 ・ 交大思诺
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies